Social media is increasingly changing the way consumers interact and behave. The massive growth in the reach of mobile tools adds to the trend significantly.
The world is getting more connected by the day and the possibilities it holds for healthcare organizations are countless. Consumers turn to their mobile devices to connect, collaborate and share knowledge by leveraging social media technology. Companies are increasingly turning to social media and mobile technology to actively engage their customers in real-time while on the move. Leading healthcare organizations are quickly catching on to this burgeoning trend and have started to embrace it in their efforts to provide affordable, quality, and timely care.
Social media and mobile technology are playing a large role in shaping the future of healthcare and are redefining the way care has been delivered for centuries. These collaborative technologies are transforming several critical aspects of the healthcare industry including the following:
Carl Ascenzo is Vice President of Global Healthcare Solutions for Virtusa.
Social media transforming healthcare interactions
Social media is moving beyond the solely social sphere to influence engagement and outcomes.
Social media is increasingly changing the way consumers interact and behave. The massive growth in the reach of mobile tools adds to the trend significantly.
The world is getting more connected by the day and the possibilities it holds for healthcare organizations are countless. Consumers turn to their mobile devices to connect, collaborate and share knowledge by leveraging social media technology. Companies are increasingly turning to social media and mobile technology to actively engage their customers in real-time while on the move. Leading healthcare organizations are quickly catching on to this burgeoning trend and have started to embrace it in their efforts to provide affordable, quality, and timely care.
Social media and mobile technology are playing a large role in shaping the future of healthcare and are redefining the way care has been delivered for centuries. These collaborative technologies are transforming several critical aspects of the healthcare industry including the following:
Carl Ascenzo is Vice President of Global Healthcare Solutions for Virtusa.
Amanda M. Shafton, DNP, CNM, FACNM | 2025 MHE Emerging Leaders in Healthcare
National director of midwifery, Ob Hospitalist Group. Ob Hospitalist Group (OBHG) provides hospitals with obstetric services.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Approves Ibtrozi For Adults With ROS1+ NSCLC
Ibtrozi had a 90% response rate in treatment naïve adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer, according to the results of a news release.
Read More
Conversations With Perry and Friends
Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
FDA Approves Enflonsia To Protect Infants During Their First RSV Season
Enflonsia is the first FDA-approved respiratory syncytial virus (RSV) preventative for infants, regardless of weight, according to the news release.
Read More
Half of Severe Hemophilia A Cases Have No Family History, Delaying Diagnosis but Not Raising Inhibitor Risk
According to a new study in Haemophilia, up to 60% of patients with severe HA have no known family history, making early diagnosis more difficult.
Read More
Amanda M. Shafton, DNP, CNM, FACNM | 2025 MHE Emerging Leaders in Healthcare
National director of midwifery, Ob Hospitalist Group. Ob Hospitalist Group (OBHG) provides hospitals with obstetric services.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Approves Ibtrozi For Adults With ROS1+ NSCLC
Ibtrozi had a 90% response rate in treatment naïve adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer, according to the results of a news release.
Read More
Conversations With Perry and Friends
Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
FDA Approves Enflonsia To Protect Infants During Their First RSV Season
Enflonsia is the first FDA-approved respiratory syncytial virus (RSV) preventative for infants, regardless of weight, according to the news release.
Read More
Half of Severe Hemophilia A Cases Have No Family History, Delaying Diagnosis but Not Raising Inhibitor Risk
According to a new study in Haemophilia, up to 60% of patients with severe HA have no known family history, making early diagnosis more difficult.
Read More